All Stories

  1. Relationship between Alzheimer's Disease and Type 2 Diabetes: Critical Review On Cellular and Molecular Common Pathogenic Mechanisms
  2. Neurofeedback Technology Reduces Cortisol Levels in Bruxismitle Patients: Assessment of Cerebral Activity and Anxiolytic Effects of Origanum majorana Essential Oil
  3. Alzheimer’s Disease, Obesity, and Type 2 Diabetes: Focus on Common Neuroglial Dysfunctions (Critical Review and New Data on Human Brain and Models)
  4. Alzheimer’s Disease and Type 2 Diabetes Relationships. I. Cellular and Molecular Common Pathological Mechanisms
  5. The relationships between neuroglial alterations and neuronal changes in Alzheimer’s disease, and the related controversies I: Gliopathogenesis and glioprotection
  6. The relationships between neuroglial and neuronal changes in Alzheimer’s disease, and the related controversies II: gliotherapies and multimodal therapy
  7. Reflections on Cerebellar Neuropathology in Classical Scrapie
  8. Glial Alterations in Aging and Alzheimer’s Disease: A Novel Basis to Understand, Prevent and Treat the Degenerative Process
  9. Hippocampal CCR5/RANTES Elevations in a Rodent Model of Post-Traumatic Stress Disorder: Maraviroc (a CCR5 Antagonist) Increases Corticosterone Levels and Enhances Fear Memory Consolidation
  10. Elevated Systemic L-Kynurenine/L-Tryptophan Ratio and Increased IL-1 Beta and Chemokine (CX3CL1, MCP-1) Proinflammatory Mediators in Patients with Long-Term Titanium Dental Implants
  11. The Long-Term Algae Extract (Chlorella and Fucus sp) and Aminosulphurate Supplementation Modulate SOD-1 Activity and Decrease Heavy Metals (Hg++, Sn) Levels in Patients with Long-Term Dental Titanium Implants and Amalgam Fillings Restorations
  12. Defective Insulin Signalling, Mediated by Inflammation, Connects Obesity to Alzheimer Disease; Relevant Pharmacological Therapies and Preventive Dietary Interventions
  13. Morphological Changes of Glia in Prion and a Prion-Like Disorder
  14. Brain local and regional neuroglial alterations in Alzheimers Disease: cell types, responses and implications.
  15. Blood-Based Biomarkers of Alzheimers Disease: Diagnostic Algorithms and New Technologies
  16. Editorial (Thematic Issue: Neuroglia in Alzheimer's Disease: From Cohort to Contestant in the Disease Progression and its Therapy)
  17. Vibrational spectroscopic analysis of peripheral blood plasma of patients with Alzheimer’s disease
  18. Ultrastructural changes in the progress of natural Scrapie regardless fixation protocol
  19. Variability in the Effects of Nicotine on Different Regions of the Brain: Changes in the Concentration of Superoxide Dismutase Isoforms
  20. Astroglial cell subtypes in the cerebella of normal adults, elderly adults, and patients with Alzheimer's disease: A histological and immunohistochemical comparison
  21. Morphological approach to assess the involvement of astrocytes in prion propagation
  22. Does Alzheimer disease exist in all primates? Alzheimer pathology in non-human primates and its pathophysiological implications (II)
  23. ¿Existe la enfermedad de Alzheimer en todos los primates? Patología Alzheimer en primates no humanos y sus implicaciones fisiopatológicas (II)
  24. Discrimination Analysis of Blood Plasma Associated with Alzheimer's Disease Using Vibrational Spectroscopy
  25. ¿Existe la enfermedad de Alzheimer en todos los primates? Afección de Alzheimer en primates no humanos y sus implicaciones fisiopatológicas (I)
  26. Infrared spectroscopic analysis of mononuclear leukocytes in peripheral blood from Alzheimer’s disease patients
  27. Changes Induced by Natural Scrapie in the Calretinin-Immunopositive Cells and Fibres of the Sheep Cerebellar Cortex
  28. Lesion-Induced Vertebrate Models of Alzheimer Dementia
  29. Diversity and Variability of the Effects of Nicotine on Different Cortical Regions of the Brain. Therapeutic and Toxicological Implications
  30. Calretinin-immunopositive Cells and Fibers in the Cerebellar Cortex of Normal Sheep
  31. Immunohistochemical increase in cyclooxygenase-2 without apoptosis in different brain areas of subchronic nicotine- and d-amphetamine-treated rats
  32. FTIR microspectroscopic analysis of the effects of certain drugs on oxidative stress and brain protein structure
  33. Amphetamine effects on brain protein structure and oxidative stress as revealed by FTIR microspectroscopy
  34. Lesions and Dysfunctions of the Nucleus Basalis as Alzheimers Disease Models: General and Critical Overview and Analysis of the Long-Term Changes in Several Excitotoxic Models
  35. Nueva célula ‘en cepillo’ (brush cell) o célula monopolar del cerebelo. Características y posible función
  36. Chronic nicotine administration increases NGF-like immunoreactivity in frontoparietal cerebral cortex
  37. Inervación de la glándula lagrimal en pacientes con síndrome de Sjögren primario: Estudio inmunohistopatológico
  38. Histochemical study of acute and chronic intraperitoneal nicotine effects on several glycolytic and Krebs cycle dehydrogenase activities in the frontoparietal cortex and subcortical nuclei of the rat brain
  39. Long-term evolution of local, proximal and remote astrocyte responses after diverse nucleus basalis lesioning (an experimental Alzheimer model): GFAP immunocytochemical study
  40. Localization of glyoxylate dehydrogenase and glyoxylate-complex molecules in the rat prefrontal cortex: enzymohistochemical and immunocytochemical study
  41. Repeated intracerebroventricular administration of β-amyloid25–35 to rats decreases muscarinic receptors in cerebral cortex
  42. Amyloid precursor proteins in the cerebellar cortex of Alzheimer's disease patients devoid of cerebellar β-amyloid deposits: immunocytochemical study of five cases
  43. Synaptic immunolocalization of glyoxylate-complex molecules in the striate areas of the rat cerebral cortex: Light and electron microscopic studies
  44. Synaptic immunolocalization of glyoxylate‐complex molecules in the striate areas of the rat cerebral cortex: Light and electron microscopic studies
  45. Ultrastructural Study of the Conjunctiva in Patients with Keratoconjunctivitis Sicca not Associated with Systemic Disorders
  46. Pyritinol facilitates the recovery of cortical cholinergic deficits caused by nucleus basalis lesions
  47. Mitochondria, brain aging and neurodegenerative disorders
  48. Inter- and intracellular communication in CNS
  49. Autoradiographic localization of receptors for glucagon-like peptide-1(7–36) amide in rat brain
  50. Morphometric and neurosecretory changes in supraoptic neurons after D-amphetamine treatment
  51. Hypotheses Concerning the Aetiology of Alzheimer's Disease
  52. Mitochondrial accumulation of Sr2+ supported by pyruvate in the cerebellar cortex of the rat. Cellular variations during aging.
  53. Study on, distribution of polyanionic substances and glycoproteins in albino rats hippocampus during post-natal development
  54. Distribution of peripherally stained neurons by the Colloidal Iron histochemical method in albino rat cerebral cortex. A quantitative study
  55. Histochemical characteristics of diphosphate nucleoside consumption in, cat and rat nervous system
  56. Diaminobenzidine oxidation in cerebellar histological sections
  57. Glycoproteins and polyanions in the synapses of rat and mouse central nervous system
  58. Localization of aspartate aminotransferase and glutamic dehydrogenase in the Edinger-Westphal and oculomotor nuclei of Lacerta lepida
  59. Mucopolysaccharides in the dog spinal cord and dorsal root ganglia
  60. A histochemical investigation on mucopolysaccharides in the dog sympathetic ganglia
  61. Histochemical study of mucopolysaccharides in the subthalamic region of rats